Zaprinast, a phosphodiesterase type-5 inhibitor, alters paced mating behavior in female rats

Physiology and Behavior

Volumn 96, Issue 2, 2009, Pages 289-293

  Clark, Ann S ^a   Meerts, Sarah H ^a   Guarraci, Fay A ^b  

^a Lamont Doherty Earth Observatory   (United States)

^b SOUTHWESTERN UNIVERSITY   (United States)

Author keywords

Nitric oxide; Paced mating behavior; Sexual behavior; Sexual dysfunction; Vaginal blood flow

Indexed keywords

CYCLIC GMP; ESTRADIOL BENZOATE; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; PROGESTERONE; ZAPRINAST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; EJACULATION; ENZYME INHIBITION; FEMALE; FEMALE GENITAL SYSTEM; GONADECTOMY; LOCOMOTION; LONG EVANS RAT; MATING; NONHUMAN; ORGAN BLOOD FLOW; PRIORITY JOURNAL; RAT; SEXUAL BEHAVIOR; VAGINA;

ANIMALS; ESTROGENS; FEMALE; MALE; MATING PREFERENCE, ANIMAL; MAXIMUM TOLERATED DOSE; OVARIECTOMY; PHOSPHODIESTERASE INHIBITORS; PROGESTERONE; PROGESTINS; PURINONES; RATS; RATS, LONG-EVANS; REACTION TIME; SEXUAL BEHAVIOR, ANIMAL; TIME FACTORS;

EID: 58149488997     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2008.10.013     Document Type: Article

References (34)

1. Kim S.W., Jeong S., Munarriz R., Kim N.N., Goldstein I., and Traish A.M. An in vivo rat model to investigate female vaginal arousal response. J Urol 171 (2004) 1357-1361
2. Boswell-Smith V., Spina D., and Page C.P. Phosphodiesterase inhibitors. Br J Pharmacol 147 (2006) S252-S257
3. Gibson A. Phosphodiesterase 5 inhibitors and nitrergic transmission - from zaprinast to sildenafil. Eur J Pharmacol 411 (2001) 1-10
4. Corbin J.D., and Francis S.H. Pharmacology of phosphodiesterase-5 inhibitors. Int J Clin Pract 56 6 (2002) 453-459
5. Al-Hijji J., Larsson B., and Batra S. Nitric oxide synthase in the rabbit uterus and vagina: hormonal regulation and functional significance. Biol Reprod 62 (2000) 1387-1392
6. Hoyle C.H., Stones R.W., Robson T., Whitley K., and Burnstock G. Innervation of vasculature and microvasculature of the human vagina by NOS and neuropeptide-containing nerves. J Anat 188 (1996) 633-644
7. D'Amati G., Di Gioa C., Bologna M., Giordano D., Giorgi M., Dolci S., et al. Type 5 phosphodiesterase expression in the human vagina. Urology 60 (2002) 191-195
8. Park K., Moreland R.B., Goldstein I., Atala A., and Traish A. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle. Biochem Biophys Res Commun 249 (1998) 612-617
9. Frye C.A., and Rhodes M.E. Zaprinast, a phosphodiesterase 5 inhibitor, overcomes sexual dysfunction produced by fluoxetine, a selective serotonin reuptake in hamsters. Neuropsychopharmacology 28 (2003) 310-316
10. Erskine M.S. Solicitation behavior in the estrous female rat: a review. Horm Behav 23 (1989) 473-502
11. Agmo A., Turi A., Ellingsen E., and Kaspersen H. Preclinical models of sexual desire: conceptual and behavioral analyses. Pharmacol Biochem Behav 78 (2004) 379-404
12. Blaustein J.D., and Erskine M.S. Feminine sexual behavior: cellular integration of hormonal and afferent information in the rodent forebrain. In: Pfaff D.W., Arnold A.P., Etgen A.M., Fahrbach S.E., and Rubin R.T. (Eds). Hormone, brain and behavior vol. 1 (2002), Academic Press, San Diego, CA 139-214
13. Hale T.M., Heaton J.P.W., and Adams M.A. A framework for the present and future development of experimental models of female sexual dysfunction. Int J Impot Res 15 Suppl 5 (2003) S75-S79
14. Pfaus J.G., Kippin T.E., and Coria-Avila G. What can animal models tell us about human sexual response. Annu Rev Sex Res 14 (2003) 1-63
15. Erskine M.S., Lehmann M.L., Cameron N.M., and Polston E.K. Co-regulation of female sexual behavior and pregnancy induction: an exploratory synthesis. Behav Brain Res 153 (2004) 295-315
16. Bermant G., and Westbrook W.H. Peripheral factors in the regulation of sexual contact by female rats. J Comp Physiol Psychol 61 (1966) 244-250
17. Clark A.S., Guarraci F.A., Megroz A.B., Porter D.M., and Henderson L.P. The display of sexual behaviors by female rats administered ICI 182,780. Horm Behav 43 (2003) 454-464
18. Clark A.S., Kelton M.C., Guarraci F.A., and Clyons E.Q. Hormonal status and test condition, but not sexual experience, modulate partner preference in female rats. Horm Behav 45 (2004) 314-323
19. Guarraci F.A., and Clark A.S. Ibotenic acid lesions of the medial preoptic area disrupt the expression of partner preference in sexually receptive female rats. Brain Res 1076 (2006) 163-170
20. O'Donnell J.M., and Frith S. Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases. Pharmacol Biochem Behav 63 (1999) 185-192
21. Uphouse L., Hiegel C., Sarkar J., Templeton C., Guptarak J., and Maswood N. Female gonadal hormones, mild restraint and male preference. Pharmacol Biochem Behav (2008) 758-762
22. Rosen R.C., and McKenna K.E. PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes. Annu Rev Sex Res 13 (2002) 36-88
23. Angulo J., Cuevas P., Cuevas B., Bischoff E., and de Tejada I. Vardenafil enhances clitoral and vaginal blood flow responses to pelvic nerve stimulation in female dogs. Int J Impot Res 15 (2003) 137-141
24. Erskine M.S., Kornberg E., and Cherry J.A. Paced copulation in rats: effects of intromission frequency and duration on luteal activation and estrus length. Physiol Behav 45 (1989) 33-39
25. Erskine M.S. Pelvic and pudendal nerves influence the display of paced mating behavior in response to estrogen and progesterone in the female rat. Behav Neurosci 106 (1992) 690-697
26. Marson L., and Foley K.A. Identification of neural pathways involved in genital reflexes in the female: a combined anterograde and retrograde tracing study. Neuroscience 127 (2004) 723-736
27. Marson L., and Murphy A.Z. Identification of neural circuits involved in female genital responses in the rat: a dual virus and anterograde tracing study. Am J Physiol Regul Integr Comp Physiol 291 (2006) R419-R428
28. Gardener H.E., and Clark A.S. Systemic ICI 182,780 alters the display of female sexual behaviors in rats. Horm Behav 39 (2001) 121-130
29. Kim N.N., Stankovic M., Armagan A., Cushman T.T., Goldstein I., and Traish A.M. Effects of tamoxifen on vaginal blood flow and epithelia morphology in the rat. BMC Women's Health 6 (2006) 14-24
30. Hoheisel U., Unger T., and Mense S. The possible role of the NO-cGMP pathway in nociception: different spinal and supraspinal action of enzyme blockers on rat dorsal horn neurones. Pain 117 (2005) 358-367
31. Patil C.S., Jain N.K., Singh V.P., and Kulkarni S.K. Differential effect of the PDE5 inhibitors, sildenafil and zaprinast, in aging- and lipopolysaccharide-induced cognitive dysfunction in mice. Drug Dev Res 63 (2004) 66-75
32. Hull E.M., and Dominguez J.M. Getting his act together: roles of glutamate, nitric oxide, and dopamine in the medial preoptic area. Brain Res 1126 (2006) 66-75
33. Chu X., and Agmo A. Sexual incentive motivation in old male rats: the effects of sildenafil and a compound (Impaza) stimulating endothelial NO synthase. Pharmacol Biochem Behav 89 (2008) 209-217
34. Kim N.N., Christianson D.W., and Traish A.M. Role of arginase in the male and female sexual arousal response. J Nutr 134 (2004) 2873S-2879S